National UK guidelines for the management of paediatric craniopharyngioma

Gan, HW; Morillon, P; Albanese, A; Aquilina, K; Chandler, C; Chang, YC; Drimtzias, E; Farndon, S; Jacques, TS; Korbonits, M; Kuczynski, A; Limond, J; Robinson, L; Simmons, I; Thomas, N; Thomas, S; Thorp, N; Vargha-Khadem, F; Warren, D; Zebian, B; Mallucci, C; Spoudeas, HA

doi:10.1016/s2213-8587(23)00162-6

Pituitary & hypothalamus

National UK guidelines for the management of paediatric craniopharyngioma

Lancet Diabetes EndocrinolPublished 4 Aug 2023Guideline

Read the original article ↗PubMed

Cite

Methodological detailsevidence-based and consensus-based, AGREE II methodology

Evidence-based and consensus-based
AGREE II methodology

Scope

As issued by the authors

Management of paediatric craniopharyngioma in the UK, to standardise care for children and young people with craniopharyngiomas

Original publication

National UK guidelines for the management of paediatric craniopharyngioma. Lancet Diabetes Endocrinol. Published 4 August 2023. doi:10.1016/s2213-8587(23)00162-6

Read the original article ↗

Composed by AI from the published abstract and checked against it. How Briefs are made →